Griffith University MRI Study Finds Glymphatic Impairment in 31 ME/CFS Patients, Linking It to Brain Fog
Updated
Updated · health.yahoo.com · Jul 7
Griffith University MRI Study Finds Glymphatic Impairment in 31 ME/CFS Patients, Linking It to Brain Fog
2 articles · Updated · health.yahoo.com · Jul 7
Summary
Frontiers in Neuroscience published Griffith University findings that MRI-based DTI-ALPS scans showed reduced glymphatic activity in 31 ME/CFS patients versus 27 healthy controls, offering direct imaging evidence behind brain fog.
Lower DTI-ALPS scores tracked with worse sleep quality and greater cognitive impairment, supporting a feedback loop in which disrupted sleep weakens the brain’s waste clearance and may fuel neuroinflammation.
The glymphatic system clears metabolites such as lactate, glutamate and beta-amyloid during sleep, placing ME/CFS into a wider research debate already active in Alzheimer’s disease and traumatic brain injury.
Researchers called the result an initial mechanistic finding rather than a clinical breakthrough, saying the non-invasive MRI method still needs replication and validation against more direct physiological measures.
Could a simple brain scan finally offer a definitive diagnosis for millions with chronic fatigue?
Is a clogged brain-drain the hidden link between Chronic Fatigue, Long-COVID, and Alzheimer's?
Now that 'brain fog' has a physical cause, what new therapies can reboot the brain's cleaning system?
Direct Evidence of Glymphatic Dysfunction in ME/CFS: A Breakthrough in Diagnosis, Mechanism, and Treatment
Overview
A recent study from Griffith University has provided the first direct evidence that the glymphatic system—the brain’s waste clearance pathway—is impaired in people with ME/CFS. This breakthrough marks a pivotal moment for both patients and researchers, as it reveals a concrete biological mechanism that may explain many of the condition’s debilitating symptoms. By identifying a measurable physiological abnormality, the discovery moves ME/CFS from a misunderstood illness to one recognized as a verifiable neurological disorder. This long-overdue validation offers hope for better diagnosis, treatment, and recognition for millions living with ME/CFS.